Page 1

INTERIM REPORT APRIL - JUNE 2021 Second quarter Revenue amounted to € 348.9m ( € 198.8m ) , an increase of 75.5 % with an organic growth of 79.0 % . ● ● ● ● Operating profit ( EBIT ) was € 46.2m ( € -2.3m ) , representing an operating margin of 13.3 % ( -1.2 % ) . Net profit amounted to € 33.5m ( € -8.5m ) , which represents a net profit margin of 9.6 % ( -4.3 % ) . EBITDA was € 71.8m ( € 25.3m ) , an increase by 183.9 % . EBITDA margin was 20.6 % ( 12.7 % ) . EBITDAAL amounted to € 58.2m ( € 12.4m ) , corresponding to an EBITDAAL margin of 16.7 % ( 6.3 % ) . MEDICOVER Net cash flow from operating activities was € 38.1m ( € 38.3m ) . Basic / diluted earnings per share were € 0.203 ( € -0.056 ) . Covid - 19 - pandemic had a net positive impact on operating performance . REVENUE AND EARNINGS € millions ( € m ) Revenue Operating profit ( EBIT ) Operating profit margin Net profit Net profit margin Basic / diluted earnings / ( loss ) per share , € EBITDA EBITDA margin EBITDAAL EBITDAAL margin Q2 2021 Q2 2020 348.9 198.8 46.2 -2.3 13.3 % -1.2 % 33.5 -8.5 9.6 % -4.3 % 0.203 71.8 20.6 % 58.2 16.7 % 48.6 13.9 % -0.056 25.3 12.7 % 12.4 6.3 % 5.2 2.6 % First half Revenue amounted to € 666.1m ( € 437.6m ) , an increase of 52.2 % with an organic growth of 56.4 % . ● ● ● Operating profit ( EBIT ) was € 87.8m ( € 4.1m ) , representing an operating margin of 13.2 % ( 0.9 % ) . Net profit amounted to € 59.8m ( € -11.0m ) , which represents a net profit margin of 9.0 % ( -2.5 % ) . EBITDA was € 137.3m ( € 54.3m ) , an increase by 152.7 % . EBITDA margin was 20.6 % ( 12.4 % ) . EBITDAAL amounted to € 111.1m ( € 29.2m ) , corresponding to an EBITDAAL margin of 16.7 % ( 6.7 % ) . Net cash flow from operating activities was € 95.8m ( € 74.9m ) . Basic / diluted earnings per share were € 0.377 ( € -0.062 ) . Growth 76 % 2,114 % 491 % 463 % 184 % 368 % 6M 2021 666.1 87.8 13.2 % 838 % 59.8 9.0 % 6M 2020 Growth 437.6 4.1 0.9 % -11.0 -2.5 % 0.377 -0.062 137.3 20.6 % 111.1 16.7 % 92.7 13.9 % 54.3 12.4 % 29.2 6.7 % 52 % 2,043 % 14.1 3.2 % 640 % 708 % 153 % EBITA EBITA margin Definition and reconciliation of alternative performance measures are available at www.medicover.com/financial-information . 280 % 559 % FY 2020 997.8 61.3 6.1 % 27.3 2.7 % 0.182 157.5 15.8 % 108.5 10.9 % 76.9 7.7 % Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics , hospitals , specialty - care facilities , laboratories and blood - drawing points and the largest markets are Poland and Germany . In 2020 , Medicover had revenue of € 998 million and more than 32,000 employees . For more information , go to www.medicover.com Medicover AB ( Publ ) | P.O. Box 5283 | SE - 102 46 Stockholm | Visiting address : Riddargatan 12A | Sweden 1